249 related articles for article (PubMed ID: 18974640)
1. Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects.
Chiang CK; Yang SY; Peng YS; Hsu SP; Pai MF; Huang JW; Hung KY; Wu KD
Am J Nephrol; 2009; 29(5):392-7. PubMed ID: 18974640
[TBL] [Abstract][Full Text] [Related]
2. Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy.
Sirken G; Kung SC; Raja R
ASAIO J; 2003; 49(4):422-5. PubMed ID: 12918584
[TBL] [Abstract][Full Text] [Related]
3. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
[TBL] [Abstract][Full Text] [Related]
4. Effects of preoperative statin therapy on cytokines after cardiac surgery.
Liakopoulos OJ; Dörge H; Schmitto JD; Nagorsnik U; Grabedünkel J; Schoendube FA
Thorac Cardiovasc Surg; 2006 Jun; 54(4):250-4. PubMed ID: 16755446
[TBL] [Abstract][Full Text] [Related]
5. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients.
Tsouchnikas I; Dounousi E; Papakonstantinou S; Ioannou K; Kelesidis A; Kotzadamis N; Xanthopoulou K; Tsakiris D
Nephrology (Carlton); 2009 Sep; 14(6):560-4. PubMed ID: 19422526
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
[TBL] [Abstract][Full Text] [Related]
8. The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.
Bielecka-Dabrowa A; Goch JH; Mikhailidis DP; Rysz J; Maciejewski M; Banach M
Med Sci Monit; 2009 Dec; 15(12):MS12-23. PubMed ID: 19946241
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins.
Hasegawa T; Zhao J; Fuller DS; Bieber B; Zee J; Morgenstern H; Hanafusa N; Nangaku M
Am J Nephrol; 2017; 46(1):11-17. PubMed ID: 28564644
[TBL] [Abstract][Full Text] [Related]
10. Statin use is associated with lower inflammation and erythropoietin responsiveness index in hemodialysis patients.
Koc M; Dogan C; Arinsoy T; Tonbul Z; Ayli D; Cirit M; Sever MS; Yilmaz ME; Unsal A; Suleymanlar G; Ok E; Basci A; Yildiz A
Hemodial Int; 2011 Jul; 15(3):366-73. PubMed ID: 21507195
[TBL] [Abstract][Full Text] [Related]
11. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
[TBL] [Abstract][Full Text] [Related]
12. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.
Regidor DL; Kopple JD; Kovesdy CP; Kilpatrick RD; McAllister CJ; Aronovitz J; Greenland S; Kalantar-Zadeh K
J Am Soc Nephrol; 2006 Apr; 17(4):1181-91. PubMed ID: 16565261
[TBL] [Abstract][Full Text] [Related]
13. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
[TBL] [Abstract][Full Text] [Related]
14. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
Dogra G; Irish A; Chan D; Watts G
Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
[TBL] [Abstract][Full Text] [Related]
16. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
Stefanadi E; Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Vavuranakis E; Triantafyllou G; Marinou K; Tsioufis C; Papageorgiou N; Latsios G; Stefanadis C
Int J Cardiol; 2009 Apr; 133(2):266-8. PubMed ID: 18187214
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
[TBL] [Abstract][Full Text] [Related]
18. Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women.
Ushiroyama T; Nosaka S; Ueki M
Int J Cardiol; 2006 Oct; 113(1):66-75. PubMed ID: 16356567
[TBL] [Abstract][Full Text] [Related]
19. Effect of protein-energy malnutrition on erythropoietin requirement in maintenance hemodialysis patients.
Akgul A; Bilgic A; Sezer S; Ozdemir FN; Olcay I; Arat Z; Haberal M
Hemodial Int; 2007 Apr; 11(2):198-203. PubMed ID: 17403171
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.
Tekin A; Sezgin N; Katircibaşi MT; Tekin G; Cölkesen Y; Sezgin AT; Müderrisoğlu H
Coron Artery Dis; 2008 Nov; 19(7):513-9. PubMed ID: 18923248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]